Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Marston Linehan

Showing results (341-350 of 487) with videos related to

Pageof 49
Sort By:
Chest|April 13, 2010
Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseasesLisa R Young, Rhonda Vandyke, Peter M Gulleman, et al.
Cancer Research|June 18, 2002
The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cellsIgor Kuzmin, John W Gillespie, Alexei Protopopov, et al.
Cancer Cell|June 13, 2006
Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancersIan J Davis, Jessica J Kim, Fatih Ozsolak, et al.
The Lancet. Oncology|September 16, 2024
Belzutifan for patients with von Hippel-Lindau disease-associated CNS haemangioblastomas (LITESPARK-004): a multicentre, single-arm, phase 2 studyOthon Iliopoulos, Ane B Iversen, Vivek Narayan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2003
Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumorJames R Vasselli, Joanna H Shih, Shuba R Iyengar, et al.
The Journal of Urology|August 21, 2012
Correlation of magnetic resonance imaging tumor volume with histopathologyBaris Turkbey, Haresh Mani, Omer Aras, et al.
Abdominal Radiology (New York)|July 22, 2022
An MRI-based radiomics model to predict clear cell renal cell carcinoma growth rate classes in patients with von Hippel-Lindau syndromePouria Yazdian Anari, Nathan Lay, Nikhil Gopal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2024
Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 StudyTobias Else, Eric Jonasch, Othon Iliopoulos, et al.
Abdominal Radiology (New York)|March 10, 2021
<sup>18</sup>Fluorodeoxyglucose-positron emission tomography/computed tomography for differentiation of renal tumors in hereditary kidney cancer syndromesMoozhan Nikpanah, Anna K Paschall, Mark A Ahlman, et al.
Cell Reports|April 13, 2025
TFE3 fusion oncoprotein condensates drive transcriptional reprogramming and cancer progression in translocation renal cell carcinomaChoon Leng So, Ye Jin Lee, Bujamin H Vokshi, et al.
Pageof 49

Showing results (341-350 of 487) with videos related to

Sort By:
Pageof 49
Chest|April 13, 2010
Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseasesLisa R Young, Rhonda Vandyke, Peter M Gulleman, et al.
Cancer Research|June 18, 2002
The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cellsIgor Kuzmin, John W Gillespie, Alexei Protopopov, et al.
Cancer Cell|June 13, 2006
Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancersIan J Davis, Jessica J Kim, Fatih Ozsolak, et al.
The Lancet. Oncology|September 16, 2024
Belzutifan for patients with von Hippel-Lindau disease-associated CNS haemangioblastomas (LITESPARK-004): a multicentre, single-arm, phase 2 studyOthon Iliopoulos, Ane B Iversen, Vivek Narayan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2003
Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumorJames R Vasselli, Joanna H Shih, Shuba R Iyengar, et al.
The Journal of Urology|August 21, 2012
Correlation of magnetic resonance imaging tumor volume with histopathologyBaris Turkbey, Haresh Mani, Omer Aras, et al.
Abdominal Radiology (New York)|July 22, 2022
An MRI-based radiomics model to predict clear cell renal cell carcinoma growth rate classes in patients with von Hippel-Lindau syndromePouria Yazdian Anari, Nathan Lay, Nikhil Gopal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2024
Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 StudyTobias Else, Eric Jonasch, Othon Iliopoulos, et al.
Abdominal Radiology (New York)|March 10, 2021
<sup>18</sup>Fluorodeoxyglucose-positron emission tomography/computed tomography for differentiation of renal tumors in hereditary kidney cancer syndromesMoozhan Nikpanah, Anna K Paschall, Mark A Ahlman, et al.
Cell Reports|April 13, 2025
TFE3 fusion oncoprotein condensates drive transcriptional reprogramming and cancer progression in translocation renal cell carcinomaChoon Leng So, Ye Jin Lee, Bujamin H Vokshi, et al.
Pageof 49